[et_pb_section fb_built=”1″ _builder_version=”4.20.2″ _module_preset=”default” background_color=”#f15e35″ global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”|800|||||||” text_font_size=”28px” header_line_height=”1.5em” global_colors_info=”{}”]<\/p>\n
DAY 2 [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” custom_padding=”3px|||||” global_colors_info=”{}”]<\/p>\n \u00a009:00 Phenotyping mitral regurgitation<\/span><\/strong> 10:10 Flash news on bicuspid aortic valve<\/span><\/strong> 10:30 Coffee break in the exhibition hall<\/span><\/strong><\/p>\n 11:00 Burning questions in TAVI<\/span><\/strong> 12:10 Flash news<\/span><\/strong> 12:30 Lunch break in the exhibition hall<\/span><\/strong><\/p>\n 14:00 Nightmare in valvular heart disease<\/span><\/strong> 15:00 Closing remarks: Eustachio Agricola, Patrizio Lancellotti<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#f15f35″ global_colors_info=”{}”][et_pb_fullwidth_image src=”https:\/\/divine-id.site\/EUROVALVE\/2023\/wp-content\/uploads\/2023\/03\/footer.png” title_text=”footer” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#f15f35″ width=”80%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_fullwidth_image][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" DAY 2 FRIDAY 22\u00a009:00 Phenotyping mitral regurgitationChairs: Eustachio Agricola, Marie Annick Clavel, Michele De Bonis09:00 Phenotyping vs. staging vs. risk scores: one better than the other? Mani Vannan09:15 Primary MR phenotypes\/stages: what do they offer? Nina Ajmone Marsan09:30 Secondary MR phenotypes\/stages: do they inform better than proportionate vs. disproportionate MR. Philippe Bertrand09:45 Phenotyping\/staging MR: beyond […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"_links":{"self":[{"href":"https:\/\/divine-id.site\/EUROVALVE\/2023\/wp-json\/wp\/v2\/pages\/5797"}],"collection":[{"href":"https:\/\/divine-id.site\/EUROVALVE\/2023\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/divine-id.site\/EUROVALVE\/2023\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/divine-id.site\/EUROVALVE\/2023\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/divine-id.site\/EUROVALVE\/2023\/wp-json\/wp\/v2\/comments?post=5797"}],"version-history":[{"count":0,"href":"https:\/\/divine-id.site\/EUROVALVE\/2023\/wp-json\/wp\/v2\/pages\/5797\/revisions"}],"wp:attachment":[{"href":"https:\/\/divine-id.site\/EUROVALVE\/2023\/wp-json\/wp\/v2\/media?parent=5797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nFRIDAY 22<\/span><\/p>\n
Chairs: Eustachio Agricola, Marie Annick Clavel, Michele De Bonis<\/span><\/strong>
09:00 Phenotyping vs. staging vs. risk scores: one better than the other? Mani Vannan<\/span>
09:15 Primary MR phenotypes\/stages: what do they offer? Nina Ajmone Marsan<\/span>
09:30 Secondary MR phenotypes\/stages: do they inform better than proportionate vs. disproportionate MR. Philippe Bertrand<\/span>
09:45 Phenotyping\/staging MR: beyond prognosis. Lukas Stolz<\/span>
10:00 Round table discussion with expert\u2019s panel. Raluca Elena Dulgheru, Vlatka Reskovic<\/span><\/p>\n
Chairs: Khalil Fattouch, Vincent Tchana Sato, Tommaso Viva<\/span><\/strong>
10:10 New classification of BAV. Nina Ajmone Marsan<\/span>
10:25 Discussion<\/p>\n
Chairs: Patrizio Lancellotti, Sebastian Ludwig<\/span><\/strong>
11:00 High Lifetime Management: valve and sequence selection. Rodolfo Citro<\/span>
11:15 Hemodynamics and durability: what have we learned from flow studies? Marie Annick Clavel<\/span>
11:30 Alternative routes. Mathieu Lempereur<\/span>
11:45 Commissural alignment and coronary access. Mariama Akodad<\/span>
12:00 Round table discussion with expert\u2019s panel. Marco Moscarelli, Marc Radermecker, Mani Vannan<\/span><\/p>\n
Chair: Marie-Annick Clavel<\/span><\/strong>
12:10 New technologies for future treatment of moderate AS. Emmanuel Messas<\/span>
12:25 Discussion<\/p>\n
Chairs: Eustachio Agricola, Khalil Fattouch, Patrizio Lancellotti<\/span><\/strong>
14:00 A patient with MR and TR. Vlatka Reskovic<\/span>
14:15 A patient with AS and MR. Giovanni La Canna<\/span>
14:30 A patient with cancer and endocarditis. Tommaso Viva<\/span>
14:45 Round table discussion with expert\u2019s panel. Rodolpho Citro, Federica Ilardi, Vlatka Reskovic<\/span><\/p>\n